PhD
Boštjan
Martinc
no.:
60360
researcher – active in research organisation
bostjan.martinc
ir-rs.si
| Code |
Science |
Field |
Subfield |
|
1.09.00
|
Natural sciences and mathematics
|
Pharmacy
|
|
|
3.07.00
|
Medical sciences
|
Metabolic and hormonal disorders
|
|
| Code |
Science |
Field |
|
B740
|
Biomedical sciences
|
Pharmacological sciences, pharmacognosy, pharmacy, toxicology
|
Clinical Pharmacy; Consultant Clinical Pharmacist; Hospital Pharmacotherapy; Comprehensive Medication Review; Medicines Optimisation; Seamless Pharmaceutical Care; Polypharmacy; Deprescribing; Deprescribing Prioritisation; Benefit–Harm Reassessment; Drug–Drug Interactions; Pharmacokinetic and Pharmacodynamic Interactions; Medication Safety; Pharmacovigilance; Signal Detection; Adverse Drug Reactions; Geriatric Pharmacotherapy; STOPP/START Criteria; PRISCUS List; Multimorbidity; Type 2 Diabetes Mellitus; Glycaemic Control; Cardiometabolic Risk; Oxidative Stress; Chronic Pain; Fibromyalgia; Opioid Stewardship; CNS Polypharmacy; Translational Pharmacotherapy; Real-World Evidence; Health Technology Assessment; Clinical Decision Support Systems; ATC Classification; PCNE Classification; Medicines Governance.
Data for the last 5 years (citations for the last 10 years) on
March 24, 2026;
Data for score A3 calculation refer to period
2020-2024
Data for ARIS tenders (
21.05.2024 – Target research programmes,
archive
)
| Database |
Linked records |
Citations |
Pure citations |
Average pure citations |
| WoS |
8
|
278
|
271
|
33.88
|
| Scopus |
6
|
319
|
312
|
52
|
| Level of education |
Professional title |
Study subject |
Faculty |
Year |
|
Bachelor's degree
|
B. Sc.
|
Pharmacy
|
University of Ljubljana, Faculty of Pharmacy
|
2006
|
|
Doctoral degree
|
Ph. D.
|
|
University of Ljubljana, Faculty of Pharmacy
|
2014
|
|
Doctoral degree
|
Ph. D.
|
Biomedicine
|
University of Ljubljana, Faculty of Pharmacy
|
2015
|
Doctoral dissertations and other final papers
Show
Peer-Reviewed Publications
• Martinc B, Grabnar I, Mrhar A, Vovk T. Rapid high-performance liquid chromatography method for determination of pregabalin in pharmaceutical dosage form following derivatization with fluorescamine. Journal of AOAC International. 2010;93(4):1069–1076.
• Martinc B, Grabnar I, Vovk T. The role of reactive species in epileptogenesis and influence of antiepileptic drug therapy on oxidative stress. Current Neuropharmacology. 2012;10(4):328–343.
• Martinc B, Grabnar I, Vovk T. Conference abstract PPAT15: A simple high-throughput method for determination of pregabalin in pharmaceutical dosage forms using a microplate fluorescence reader. Sci Pharm. 2010;78:704.
• Martinc B, Vovk T. A simple high-throughput method for determination of antiepileptic analogues of γ-aminobutyric acid in pharmaceutical dosage forms using a microplate fluorescence reader. Chemical and Pharmaceutical Bulletin. 2013;61(10):1009–1014.
• Martinc B, Grabnar I, Roškar R, Vovk T. Simultaneous determination of gabapentin, pregabalin, vigabatrin, and topiramate in plasma by HPLC with fluorescence detection. Journal of Chromatography B. 2014;962:82–88.
• Martinc B, Grabnar I, Roškar R, Vovk T. Antioxidants as a preventive treatment for epileptic process: a review of the current status. Current Neuropharmacology. 2014;12(6):527–550.
• Martinc B. Recognition of metformin-associated lactic acidosis and appropriate pharmaceutical management. Farmacevtski vestnik. 2015;66(4):349–353.
• Martinc B. Novelties in pharmacotherapy of type 2 diabetes. Farmacevtski vestnik. 2016;67(2–3):117–126.
• Martinc B. Drug-induced liver injury. Farmacevtski vestnik. 2019;70(4):272–279.
• Martinc B. Advances in treatment with SGLT2 inhibitors and GLP-1 receptor agonists. Farmacevtski vestnik. 2022;73(2):115–127.
Book Chapter
• Martinc B. Curcumin. In: Minerals, Vitamins and Other Selected Substances. Slovenian Pharmaceutical Society (SFD); 2020.
Selected Invited Lectures and Professional Education
• National Diabetes Programme 2010–2020 and pharmaceutical care – Continuing education programme, Ljubljana and Maribor, 2014.
• Oral antidiabetic therapy – Continuing education programme, 2014.
• Hypoglycaemia in type 2 diabetes treated with oral antidiabetics – MSD workshop for pharmacists, 2014.
• Pharmaceutical care in diabetes – National training workshop for beginner moderators, Slovenian Chamber of Pharmacy, 2014.
• Pharmacotherapy of diabetes – Doctoral programme in Biomedicine, Faculty of Pharmacy, 2015.
• Pharmaceutical care in arterial hypertension – PCNE-SLO-V1 classification system workshop, 2015.
• Adverse drug reactions: recognition of metformin-associated lactic acidosis – Symposium of Public Pharmacy Section, 2015.
• Glucose and lipid measurement systems – Professional training programme, Faculty of Pharmacy, 2021.
• Pharmaceutical care in patients with hypertension and diabetes – Continuing education programme, 2022.
• Advances in SGLT2 inhibitors and GLP-1 receptor agonists – 47th Assembly of SFD, 2022.
• Diabetes in association with anaemia and venous thrombosis – 11th Symposium of Clinical Pharmacists Section, 2022.
• Lipid-modifying agents – National continuing education programme, 2023.
• Advances in glucose monitoring in diabetes – 48th Assembly of SFD, 2023.
• E-education module: Glucose monitoring in people with diabetes, Slovenian Chamber of Pharmacy, 2023.
Conference Abstracts
• Martinc B, Grabnar I, Vovk T. HPLC method for simultaneous determination of four second-generation antiepileptic drugs in plasma. 4th BBBB-Bosphorus International Conference on Pharmaceutical Sciences, Bled, 2011.
• Martinc B. Best practice: Pharmacy for the patient. National Diabetes Conference, Ljubljana, 2014.
• Martinc B, Brus I. Pharmacy-based hypertension and diabetes management program in Slovenian pharmacies. 75th FIP International Congress, Düsseldorf, 2015.